Your browser doesn't support javascript.
loading
Validation of MoCA-MMSE Conversion Scales in Korean Patients with Cognitive Impairments
Article de En | WPRIM | ID: wpr-718820
Bibliothèque responsable: WPRO
ABSTRACT
BACKGROUND AND PURPOSE: Two conversion scales between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) have been validated for Korean patients with Parkinson's disease. The aim of the present study was to validate these conversion scales for all patients with cognitive impairments regardless of dementia subtype. METHODS: Medical records of 323 subjects who completed both MMSE and MoCA on the same day were retrospectively reviewed. Mean, median, and root mean squared error (RMSE) of the difference between true and equivalent MMSE scores were calculated. Intraclass correlation coefficients (ICCs) between true and equivalent MMSE scores were also calculated. The validity of MoCA-MMSE conversion scales was evaluated according to educational level (low educated: ≤6 years; high educated: ≥7 years) and subtypes of cognitive impairment. RESULTS: The difference between true and equivalent MMSE scores had a median value of 0, a mean value of 0.19 according to the van Steenoven scale, a mean value of 0.57 according to the Lawton scale, RMSE value of 2.2 according to the van Steenoven scale, and RMSE value of 0.42 according to the Lawton scale. Additionally, ICCs between true and equivalent MMSE scores were 0.92 and 0.90 on van Steenovan and Lawton conversion scales, respectively. These results were maintained in subgroup analyses. CONCLUSIONS: Findings of the present study suggest that both van Steenovan and Lawton MoCA-MMSE conversion scales are applicable to transforming MoCA scores into MMSE scores in patients with cognitive impairments regardless of dementia subtype or educational level.
Sujet(s)
Mots clés
Texte intégral: 1 Indice: WPRIM Sujet Principal: Maladie de Parkinson / Poids et mesures / Dossiers médicaux / Études rétrospectives / Troubles de la cognition / Démence / 2,2'-Dichloro-4,4'-méthylènedianiline Type d'étude: Observational_studies Limites du sujet: Humans langue: En Texte intégral: Dementia and Neurocognitive Disorders Année: 2018 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Maladie de Parkinson / Poids et mesures / Dossiers médicaux / Études rétrospectives / Troubles de la cognition / Démence / 2,2'-Dichloro-4,4'-méthylènedianiline Type d'étude: Observational_studies Limites du sujet: Humans langue: En Texte intégral: Dementia and Neurocognitive Disorders Année: 2018 Type: Article